Elizabeth Lam-Yan Ng

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
In recent years, molecular research has translated into remarkable changes for breast cancer diagnostics and therapeutics. Molecular tests such as Oncotype DX® and MammaPrint® have revolutionized the predictive and prognostic tools in the clinic. By stratifying the risk of recurrence for patients, the tests are able to provide clinicians with more(More)
  • 1